Brendan Curti
MD
Director, Cancer Immunotherapy Program
👥Biography 个人简介
Brendan Curti has led early-phase clinical evaluation of next-generation armed oncolytic herpes viruses including RP2 and RP3 in solid tumors. His work has characterized the immune-activating consequences of intratumoral oncolytic virus delivery and the potential for systemic abscopal responses. He has contributed to defining safety profiles and preliminary efficacy signals for engineered oncolytic virus platforms.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Brendan Curti 的研究动态
Follow Brendan Curti's research updates
留下邮箱，当我们发布与 Brendan Curti（Providence Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment